Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-899-1 | CAS number: 75-76-3
Endpoint summary
Administrative data
Description of key information
In the key acute oral toxicity study, conducted according to OECD 401 and in compliance with GLP, the LD50 for male and female rats was >2000 mg/kg (Huls, 1998). Clinical symptoms were noticed 30 minutes to six hours after treatment. Abnormal gait, squatting position, sedation, paddling movements, piloerection, diarrhea and diuresis were observed. From day one until the end of the study (day 14) no other clinical signs were observed. No abnormalities were detected at necropsy.
In the acute inhalation study, conducted in accordance with OECD 403 and in compliance with GLP, the LC50 was determined to be >21.3 mg/l in male and female rats (Muijer, 1998). There were no mortalities or clinical signs of toxicity. Findings at necropsy consisted of abnormalities in the lungs, intestines and testes. Abnormalities of the lungs consisted of petechiae and/or hyalin spots or areas on one or more lobes in most animals. Pale discolouration of the lungs was seen in one male animal.
In the key acute dermal toxicity study, conducted according to OECD 402 and in compliance with GLP, the LD50 for male and female rats was determined to be >2000 mg/kg. (Huls, 1998). There were no clinical signs, signs of local irritation or abnormalities at necropsy.
Key value for chemical safety assessment
Additional information
The key acute oral and dermal toxicity studies (Huls, 1998a and Huls, 1998b) were the only available data for those endpoints. The studies were conducted in accordance with appropriate OECD test guidelines and in compliance with GLP, and were therefore assigned Reliability 1.
The key acute inhalation toxicity study (Muijer, 1998) was selected as the most reliable study available for this endpoint. It was conducted according to OECD 403 and in compliance with GLP, and was therefore assigned Reliability 1. An additional non-standard inhalation study is available in which the exposure duration was only 30 minutes.
Justification for classification or non-classification
Based on reliable measured data for the oral, inhalation and dermal routes, tetramethylsilane is not classified for acute toxicity according to EU Directive 67/548/EEC and Regulation 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Route: .live1